Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › BCMA antibodies and use of same to treat cancer and immunological disorders

BCMA antibodies and use of same to treat cancer and immunological disorders

US Patent 11767365 · Granted Sep 26, 2023

Estimated economic value: $336,761,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-αVβ6 antibodies and antibody-drug conjugates2025
Anti-αVβ6 antibodies and antibody-drug conjugates2025
CD47 antibodies and uses thereof for treating cancer2024
CD47 antibodies and uses thereof for treating cancer2024
Antibody libraries2024
Cysteine mutated antibodies for conjugation2024
Anti-AVB6 antibodies and antibody-drug conjugates2023
Anti-AVB6 antibodies and antibody-drug conjugates2023
Glypican 3 antibodies and conjugates thereof2023
Antibodies against BACE1 and use thereof for neural disease immunotherapy2023
Anti-CD228 antibodies and antibody-drug conjugates2023
T cells surface-loaded with immunostimulatory fusion molecules and uses thereof2022